G GERMAN INTERNATIONAL CLINICS
LIVE

Serial Number

79264358

Owner

Gerhard Siebenhüner

Attorney

Margaret C. McHugh

Filing Date

Jun 13, 2019

Add to watchlist:

No watchlists yet
View on USPTO

G GERMAN INTERNATIONAL CLINICS Trademark

Serial Number: 79264358 • Registration: 6263292

G GERMAN INTERNATIONAL CLINICS is a trademark filed by Gerhard Siebenhüner on June 13, 2019. The trademark is classified under Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Gerhard Siebenhüner

Burgstraße 8

Entity Type: 01

Trademark Details

Filing Date

June 13, 2019

Registration Date

February 9, 2021

Published for Opposition

November 24, 2020

Goods & Services

Hygienic care for human beings or animals

Medical and veterinary apparatus and instruments, namely, blood filters, blood purification filters, filters for removing toxins, pesticides, parasites, drugs, poisons, heavy metals, bacteria, viruses, immunopathogenic agents, bilirubin, and beta 2 microglobulin, drug delivery filters sold empty, fluid filters, peristaltic filters, artificial membrane filters, centrifugal pumps for blood preparation, blood transport, oxygen transport, adsorbers for blood purification, toxin, pesticide, parasite, drug, poison, heavy metal, bacteria, virus, immunopathogenic agent, bilirubin, and beta 2 microglobulin, heat exchangers, oxygenators, devices for ozone production in the nature of ozone generators, ozone devices for the treatment of blood, ozone devices for the killing and removal of bacteria, viruses, and parasites, tube systems comprised of tubes for passing blood and fluids, hemoperfusion devices, blood purification devices, devices for inducing hyperthermia, devices for thermotherapy, blood perfusion devices, perfusion devices for the treatment of blood, perfusion cutlery for surgery; medical and veterinary apparatus and instruments, namely, diagnostic and therapeutic equipment for use in the pharmaceutical, medical and veterinary fields, namely, equipment for blood gas analysis, devices for measuring blood coagulation, devices for measuring oxygen saturation, devices for measuring body temperature, hemoperfusion devices for the treatment of blood, clinical laboratory analyzers for blood and blood component analysis, chemistry analyzers for blood and blood component analysis, automated sample handling equipment for testing purposes, immunohematology analyzer for blood and blood component analysis, apparatus for blood screening, blood typing, and detection of assays associated with blood screening and blood typing used in the transfusion medicine market; Medical equipment for use in treating hyperthermia, and for thermotherapy, chemotherapy, electrochemical therapy, or radiotherapy, namely, heat exchangers, devices for inducing hyperthermia, devices for thermotherapy, infusion equipment sold empty for drug delivery, pain therapy, blood purification, and blood perfusion, radiotherapy equipment, and medical apparatus for treating diseases in the nature of cancer, borreliose, chronical diseases, and regenerative diseases, namely, filters, pumps, adsorbers, heat exchangers, oxygenators, ozone devices, tube systems, hemoperfusion devices, blood purification devices, devices for inducing hyperthermia, devices for thermotherapy, perfusion devices, and perfusion cutlery; medical apparatus for treating hyperthermia or carrying out apheresis, namely, heat exchangers, devices for inducing hyperthermia, devices for thermotherapy, and apheresis devices or units for filtering, purification, detoxification and separation of blood

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 9, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
May 30, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 11, 2021 FICS
FINAL DISPOSITION PROCESSED
May 11, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 9, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 9, 2021 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 23, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 6, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 6, 2021 OPNR
NOTIFICATION PROCESSED BY IB
Dec 19, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 27, 2020 OPNS
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 24, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 24, 2020 PUBO
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 4, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 4, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 20, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 20, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 20, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 20, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 7, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 6, 2020 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Aug 4, 2020 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Aug 4, 2020 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Aug 4, 2020 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 7, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 13, 2020 GNFN
FINAL REFUSAL E-MAILED
Apr 13, 2020 GNFR
FINAL REFUSAL WRITTEN
Apr 13, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2020 TROA
REFUSAL PROCESSED BY IB
Oct 26, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 5, 2019 RFCS
REFUSAL PROCESSED BY MPU
Oct 5, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 20, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 19, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 4, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 13, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 9, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 1, 2019 REPR